Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancer and chromosomes].

K Tanaka1, N Kamada

  • 1Dept. of Hematology, Hiroshima University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 1, 1989
PubMed
Summary

Recent cytogenetic advances reveal specific chromosome aberrations in leukemia, lymphoma, and solid tumors. These findings improve understanding of cancer development, diagnosis, and therapy, paving the way for molecular genetics insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein.

The Journal of biological chemistry·1992
Same author

The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.

Cancer·1992
Same author

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination.

Nature·1992
Same author

[Antitumor effect of locally injected TNF.fibrin gel against murine colon 26 subcutaneous tumor: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

[Clinical studies on cefprozil granules in pediatric skin soft tissues infections].

The Japanese journal of antibiotics·1992
Same author

Generalized resistance to thyroid hormone (GRTH) in a family: case studies.

Endocrinologia japonica·1992

Area of Science:

  • Cytogenetics
  • Human Hematological Malignancies
  • Solid Tumors

Context:

  • Non-random chromosome aberrations are increasingly identified in leukemia and lymphoma.
  • Specific aberrations, previously rare, are now recognized in acute leukemia subtypes.
  • Recurrent chromosome deletions are linked to secondary aberrations in tumor development.

Purpose:

  • To review recent advances in cytogenetics for human hematological malignancies and solid tumors.
  • To highlight specific chromosome aberrations and their significance in cancer development.
  • To explore the role of cytogenetics in diagnosis and therapy of cancers.

Summary:

  • The review details novel chromosome aberrations in leukemia and lymphoma, including specific translocations and deletions.
  • Simultaneous analysis of morphology, immunophenotype, and karyotype aids in identifying leukemia's stem cell origin.
  • Advances in in situ hybridization enable precise detection of chromosomal abnormalities in metaphase and interphase cells.
  • Cytogenetic studies in solid tumors have identified recurrent aberrations, aiding diagnosis and therapy correlation.

Impact:

  • Cytogenetic findings offer new concepts for the pathophysiology of malignant tumors.
  • These advances contribute to a deeper understanding of molecular genetics in human solid tumors.
  • Improved diagnostic and therapeutic orientation through correlation of chromosome changes with histologic subtypes.

Related Experiment Videos